Elanco Animal Health has appointed four new members to the Board of Directors, Deborah Kochevar, Denise Scots-Knight, John Bilbrey, and Kirk McDonald, following Lilly’s full divestiture of Elanco, and Elanco becoming a fully independent company. The Board’s diversity will enable continued value creation and transformation, and a customer-driven culture and involvement-based leadership. These four new members have a strong track record of board experience and governance as well as an exceptional combination of experiences from livestock production, veterinary medicine and innovation to digital transformation, food industry expertise and consumer insights.
“Elanco appoints four new board members“
Jeff Simmons, Elanco’s president and CEO, said: “I’m humbled by the caliber of talent and interest we found during our search process. The new board members bring together the best, diverse thinking from a wide array of experts, which will be critical to Elanco’s future. I’m looking forward to their insights and expertise as we execute our strategic plan, grow as a public company and progress our productivity agenda to create shareholder value.”